Czechia – Immunosuppressive agents – LP containing bimekizumab 2026
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
The subject of the public contract is the recurring supply of medicinal products containing the active substance bimekizumab, which meet the requirements of SÚKL
Related Procurement Opportunities
Similar tenders in Services